These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 17376272

  • 1. [Treatment effects of antithrombin-III on coagulation abnormalities in rats with endotoxaemia].
    Qiao YJ, Zhu JM, You XL, Zhang Y.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):165-7. PubMed ID: 17376272
    [Abstract] [Full Text] [Related]

  • 2. [Reproduction of a rat model of disseminated intravascular coagulation accompanied by multiple organ injuries].
    Qiao YJ, Zhu JM, Zhang Y, Yuan HY.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):41-3. PubMed ID: 17207364
    [Abstract] [Full Text] [Related]

  • 3. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y, Ohishi R, Takei R, Matsuzaki O, Mohri M, Saitoh K, Gomi K, Sugihara T, Kiyota T, Yamamoto S.
    Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
    [Abstract] [Full Text] [Related]

  • 4. [Effects of urokinase intervention on endotoxin-induced DIC in Wistar rat model].
    Yuan KF, Liao XM, Yu L, Niu T, Zhang XL, Liu WP, Liao DY, Meng WT, Fei XF.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 41(6):965-9. PubMed ID: 21265095
    [Abstract] [Full Text] [Related]

  • 5. 6,7-Dihydroxy-3-phenylcoumarin inhibits thromboplastin induced disseminated intravascular coagulation.
    Tunali T, Yarat A, Bulut M, Emekli N.
    Br J Haematol; 2004 Jul; 126(2):226-30. PubMed ID: 15238144
    [Abstract] [Full Text] [Related]

  • 6. Antithrombin-III treatment limits disseminated intravascular coagulation in endotoxemia.
    Redens TB, Emerson TE.
    Circ Shock; 1989 May; 28(1):49-58. PubMed ID: 2731321
    [Abstract] [Full Text] [Related]

  • 7. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
    Asakura H, Suga Y, Yoshida T, Ontachi Y, Mizutani T, Kato M, Ito T, Morishita E, Yamazaki M, Miyamoto K, Nakao S.
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
    [Abstract] [Full Text] [Related]

  • 8. Choline or CDP-choline attenuates coagulation abnormalities and prevents the development of acute disseminated intravascular coagulation in dogs during endotoxemia.
    Yilmaz Z, Ozarda Y, Cansev M, Eralp O, Kocaturk M, Ulus IH.
    Blood Coagul Fibrinolysis; 2010 Jun; 21(4):339-48. PubMed ID: 20410813
    [Abstract] [Full Text] [Related]

  • 9. Pre-treatment with bone marrow-derived mesenchymal stem cells inhibits systemic intravascular coagulation and attenuates organ dysfunction in lipopolysaccharide-induced disseminated intravascular coagulation rat model.
    Wang B, Wu SM, Wang T, Liu K, Zhang G, Zhang XQ, Yu JH, Liu CZ, Fang CC.
    Chin Med J (Engl); 2012 May; 125(10):1753-9. PubMed ID: 22800895
    [Abstract] [Full Text] [Related]

  • 10. Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat.
    Emerson TE, Fournel MA, Leach WJ, Redens TB.
    Circ Shock; 1987 May; 21(1):1-13. PubMed ID: 3545529
    [Abstract] [Full Text] [Related]

  • 11. [Effects of antithrombin-III on cytokines in rats with multiple organ dysfunction syndrome].
    Ren XS, Qiao YJ, Xia XH, Xu J, Jia HY.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):565-7. PubMed ID: 16146608
    [Abstract] [Full Text] [Related]

  • 12. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
    McGlasson DL, Harroff HH, Sutton J, Dick E, Elston DM.
    Clin Lab Sci; 2007 Sep; 20(2):99-105. PubMed ID: 17557708
    [Abstract] [Full Text] [Related]

  • 13. Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis.
    Dickneite G, Pâques EP.
    Thromb Haemost; 1993 Feb 01; 69(2):98-102. PubMed ID: 8456437
    [Abstract] [Full Text] [Related]

  • 14. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
    Aibiki M, Fukuoka N, Nishiyama T, Maekawa S, Shirakawa Y.
    Shock; 2007 Aug 01; 28(2):141-7. PubMed ID: 17515857
    [Abstract] [Full Text] [Related]

  • 15. Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Fujita M, Izutani W, Komurasaki Y.
    Thromb Haemost; 2000 Jul 01; 84(1):54-8. PubMed ID: 10928470
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
    Hanada T, Abe T, Takita H.
    Am J Pediatr Hematol Oncol; 1985 Jul 01; 7(1):3-8. PubMed ID: 4037242
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Changes in the coagulation profile of cattle with left abomasal displacement.
    Sobiech P, Radwińska J, Krystkiewicz W, Snarska A, Stopyra A.
    Pol J Vet Sci; 2008 Jul 01; 11(4):301-6. PubMed ID: 19227127
    [Abstract] [Full Text] [Related]

  • 20. Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III.
    Uchiba M, Okajima K.
    Semin Thromb Hemost; 1997 Jul 01; 23(6):583-90. PubMed ID: 9469634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.